{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-140955","form_type":"8-K","ticker":"INGN","cik":"0001294133","company_name":"Inogen Inc","filed_at":"2024-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.000676+00:00","generated_at":"2026-05-28T22:39:32.902720+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Inogen receives FDA 510(k) clearance for SIMEOX 200, triggering $13M milestone payment","bullets":["FDA cleared SIMEOX 200 for airway clearance and bronchial drainage in patients with chronic lung diseases.","Clearance triggers $13M cash earnout payment to Physio-Assist sellers under July 2023 purchase agreement.","Device targets mucus hypersecretion in Bronchiectasis, COPD, Cystic Fibrosis, and Primary Ciliary Dyskinesia.","Inogen plans limited U.S. launch in 2025 via existing HCP, B2B, and direct-to-patient channels."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-140955","json":"https://secwatch.observer/filing/0000950170-24-140955.json","markdown":"https://secwatch.observer/filing/0000950170-24-140955.md","text":"https://secwatch.observer/filing/0000950170-24-140955.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1294133/000095017024140955/0000950170-24-140955-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1294133/000095017024140955/ingn-20241230.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T22:39:32.902720+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}